TREA

79204234 - EXIQON

Follow

Information

  • Trademark
  • 79204234
  • Serial Number
    79204234
  • Registration Number
    5547745
  • Filing Date
    October 04, 2016
    8 years ago
  • Registration Date
    August 28, 2018
    6 years ago
  • Transaction Date
    April 03, 2021
    3 years ago
  • Status Date
    August 28, 2018
    6 years ago
  • Published for Opposition Date
    June 12, 2018
    6 years ago
  • Location Date
    August 28, 2018
    6 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MCCARTHY, BRIDGET ANN
  • Law Office Assigned Location Code
    N70
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
EXIQON
Case File Statements
  • GS0011: Chemical, biochemical and biological products, namely, reagents and tissues and reagents for industrial and scientific purposes; diagnostic reagents, except for medical or veterinary use; biochemical reagents and products, comprising industrial chemicals, catalysts for chemical and biochemical processes and chemical assays for analysis of nucleic acid, nucleotide bases, oligo nucleotide bases, DNA and RNA, used for non-medical purposes; chemical reagents except for medical or veterinary purposes; biochemical kits comprising chemicals, catalysts for chemical and biochemical processes, chemical and biochemical assays, biochemical probes, biochemical reagents and enzymes, not for medical or veterinary purposes, for analysis of genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA and for detecting RNA and microRNA; biochemical probes and microarray probes for analysis of DNA, RNA, nucleotide bases, oligo nucleotide bases, nucleic acid and for detecting RNA and microRNA - not for medical and veterinary purposes
  • GS0051: Chemical, biochemical and biological preparations, products, namely, reagents and tissues, and reagents for pharmaceutical, medical and veterinary purposes, namely, clinical medical reagents, diagnostic reagents, and assays for medical use; chemical pharmaceutical preparations, namely, for use in the detection of cancer in humans and animals and for use in oncology and for use in the prevention, treatment and cure of cancer; chemical reagents for medical and veterinary purposes; chemical preparations for therapeutic purposes for the detection of cancer in humans and animals and for the treatment, prevention and cure of cancer and for use in oncology; diagnostic preparations for medical and veterinary purposes
  • GS0091: Apparatus for recording, transmission and reproduction of sound or images; prerecorded magnetic data carriers featuring information about biochemical research results and biochemical products and solutions for use in database management, prerecorded recording discs featuring information about biochemical research results and biochemical products and solutions for use in database management; compact discs, featuring data for use in connection with chemical and biochemical analyses of genes, DNA, RNA, nucleic acid, nucleotide bases, oligo nucleotide bases; DVDs, featuring data for use in connection with chemical and biochemical analyses of genes, DNA, RNA, nucleic acid, nucleotide bases, oligo nucleotide bases and other digital recording media, namely, prerecorded digital video discs and prerecorded digital versatile discs featuring information about biochemical research results and biochemical products and solutions; downloadable computer software for use in database management; downloadable cloud computing software for managing virtual machines on a cloud computing platform, and application software for computers for use in database management
  • GS0421: Research, development of chemical, biochemical and biological products, industrial analysis, validation experiments and non-business consultancy relating to chemical analyses of genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA; biotechnical consultancy relating to genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA, peptide syntheses and nucleotide syntheses; assay development, screening biomarker detection and development projects in the nature of biochemical and biological product development, sampling of biochemical and biological products, method development of analysis of genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA and validation projects in the nature of analysis of genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA, the aforesaid services for use in relation to biotechnological industry and biotechnological and biological research and development; biochemical and biological sequencing, the aforesaid services for use in relation to biotechnological industry and biotechnological and biological research and development; design and development of computer software, including cloud computing and application software for computers; scientific consultancy services relating to DNA peptide and nucleotide syntheses
  • TR0010: The wording "EXIQON" has no meaning in a foreign language.
Case File Event Statements
  • 4/3/2021 - 3 years ago
    35 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 4/19/2019 - 5 years ago
    34 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/15/2019 - 5 years ago
    33 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 1/5/2019 - 5 years ago
    32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/13/2018 - 5 years ago
    31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/12/2018 - 5 years ago
    30 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/28/2018 - 5 years ago
    29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/28/2018 - 6 years ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/12/2018 - 6 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/8/2018 - 6 years ago
    26 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 5/23/2018 - 6 years ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/23/2018 - 6 years ago
    24 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/23/2018 - 6 years ago
    23 - NOTICE OF PUBLICATION Type: NPUB
  • 5/8/2018 - 6 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/3/2018 - 6 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/2/2018 - 6 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/2/2018 - 6 years ago
    19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/16/2017 - 6 years ago
    18 - NON-FINAL ACTION MAILED Type: CNRT
  • 11/15/2017 - 6 years ago
    17 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/8/2017 - 7 years ago
    16 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN
  • 10/27/2017 - 7 years ago
    15 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 10/25/2017 - 7 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/25/2017 - 7 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/23/2017 - 7 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 10/9/2017 - 7 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/30/2017 - 7 years ago
    10 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/13/2017 - 7 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/21/2017 - 7 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/21/2017 - 7 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/19/2017 - 7 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/18/2017 - 7 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/7/2017 - 7 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 4/3/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/3/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/30/2017 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR